---
layout: post
title: "Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants of Prescription Drug User Fee Act Products; Draft Guidance for Industry; Availability"
date: 2026-02-05 18:56:55 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-20592
original_published: 2023-09-22 00:00:00 +0000
significance: 8.00
---

# Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants of Prescription Drug User Fee Act Products; Draft Guidance for Industry; Availability

**Published:** February 05, 2026 18:56 UTC
**Source:** Federal Register
**Original Published:** September 22, 2023 00:00 UTC
**Document Number:** 2023-20592

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products." This draft guidance outlines the recommendations to industry on formal meetings between the FDA and sponsors or applicants relating to the development and review of new drug or biological drug products. This draft guidance replaces the guidance "Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products" issued on December 29, 2017.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/09/22/2023-20592/formal-meetings-between-the-food-and-drug-administration-and-sponsors-or-applicants-of-prescription)
- API: https://www.federalregister.gov/api/v1/documents/2023-20592

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
